These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques. Nagano Y; Nakamura T; Matsuzawa Y; Cho M; Ueda Y; Kita T Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845 [TBL] [Abstract][Full Text] [Related]
4. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms. Hoshida S; Yamashita N; Kawahara K; Kuzuya T; Hori M Circulation; 1999 Jan; 99(3):434-40. PubMed ID: 9918532 [TBL] [Abstract][Full Text] [Related]
5. Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect? Finckh B; Niendorf A; Rath M; Beisiegel U Eur J Clin Pharmacol; 1991; 40 Suppl 1():S77-80. PubMed ID: 2044649 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. Witting P; Pettersson K; Ostlund-Lindqvist AM; Westerlund C; Wâgberg M; Stocker R J Clin Invest; 1999 Jul; 104(2):213-20. PubMed ID: 10411551 [TBL] [Abstract][Full Text] [Related]
7. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Daugherty A; Zweifel BS; Schonfeld G Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742 [TBL] [Abstract][Full Text] [Related]
8. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits. O'Brien K; Nagano Y; Gown A; Kita T; Chait A Arterioscler Thromb; 1991; 11(3):751-9. PubMed ID: 2029510 [TBL] [Abstract][Full Text] [Related]
9. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709 [TBL] [Abstract][Full Text] [Related]
10. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits. Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933 [TBL] [Abstract][Full Text] [Related]
11. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits. Braesen JH; Beisiegel U; Niendorf A Virchows Arch; 1995; 426(2):179-88. PubMed ID: 7757289 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. Bräsen JH; Koenig K; Bach H; Kontush A; Heinle H; Witting PK; Ylä-Herttuala S; Stocker R; Beisiegel U Atherosclerosis; 2002 Aug; 163(2):249-59. PubMed ID: 12052471 [TBL] [Abstract][Full Text] [Related]
13. Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Narumiya S; Kawai C Am J Cardiol; 1988 Jul; 62(3):13B-19B. PubMed ID: 3394648 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of atherosclerosis using an antioxidant]. Ishii K; Kita T Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):177-81. PubMed ID: 2384991 [TBL] [Abstract][Full Text] [Related]
15. Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbit. Wines PA; Schmitz JM; Pfister SL; Clubb FJ; Buja LM; Willerson JT; Campbell WB Arteriosclerosis; 1989; 9(2):195-202. PubMed ID: 2647071 [TBL] [Abstract][Full Text] [Related]
16. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits. Nagano Y; Kita T; Yokode M; Ishii K; Kume N; Otani H; Arai H; Kawai C Arteriosclerosis; 1989; 9(4):453-61. PubMed ID: 2751475 [TBL] [Abstract][Full Text] [Related]
17. The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits. Djahansouzi S; Braesen JH; Koenig K; Beisiegel U; Kontush A Atherosclerosis; 2001 Feb; 154(2):387-98. PubMed ID: 11166771 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis. Atkinson JB; Hoover RL; Berry KK; Swift LL Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197 [TBL] [Abstract][Full Text] [Related]
19. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits. Lauridsen ST; Mortensen A Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518 [TBL] [Abstract][Full Text] [Related]
20. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Kleinveld HA; Demacker PN; Stalenhoef AF Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]